Premium Nahrungsergänzungsmittel | artgerecht

Pulmonary Emphysema: Causes, Symptoms & Treatment

Pulmonary emphysema is a chronic lung disease in which the air sacs are permanently destroyed, leading to progressive breathlessness and reduced lung function.

Regular tips about health Regular tips about health

Things worth knowing about "Emphysema"

Pulmonary emphysema is a chronic lung disease in which the air sacs are permanently destroyed, leading to progressive breathlessness and reduced lung function.

What is Pulmonary Emphysema?

Pulmonary emphysema is a chronic obstructive lung disease characterized by the irreversible destruction and abnormal enlargement of the tiny air sacs in the lungs, known as alveoli. As the alveolar walls break down, the surface area available for gas exchange decreases dramatically, resulting in progressive shortness of breath. Emphysema is a major component of chronic obstructive pulmonary disease (COPD).

Causes

The leading cause of pulmonary emphysema is cigarette smoking. Tobacco smoke triggers chronic inflammation in the lung tissue, which leads to the gradual breakdown of the alveolar walls. Other contributing causes include:

Alpha-1 antitrypsin deficiency: A genetic disorder that leaves the lung tissue unprotected against enzyme-mediated damage, often causing emphysema at a younger age.
Air pollution: Long-term exposure to particulate matter, industrial fumes, or occupational dust and chemicals.
Recurrent respiratory infections: Repeated severe lung infections can cause lasting structural damage.
Age-related changes: So-called senile emphysema results from natural aging of the lung tissue.

Symptoms

Emphysema develops slowly over many years. Common symptoms include:

Exertional dyspnea: Shortness of breath initially during physical activity, later also at rest.
Chronic cough: Often accompanied by mucus production, especially in the morning.
Barrel chest: The overinflated lungs cause the chest to take on a characteristic rounded, barrel-shaped appearance.
Cyanosis: Bluish discoloration of the lips and fingernails in cases of severe oxygen deficiency.
Weight loss and fatigue: Due to the increased energy required for breathing.

Diagnosis

Diagnosis is typically based on a combination of clinical findings and diagnostic tests:

Spirometry / Pulmonary function testing: Measures lung capacity and airflow; an obstructive pattern with reduced FEV1 is characteristic.
Body plethysmography: Determines residual volume and total lung capacity, both of which are elevated in emphysema.
CT scan of the chest: The gold standard for visualizing alveolar destruction and hyperinflation.
Arterial blood gas analysis: Assesses oxygen and carbon dioxide levels in the blood.
Alpha-1 antitrypsin serum level: To rule out a genetic deficiency, especially in younger patients.

Treatment

There is currently no cure for pulmonary emphysema, as the destruction of lung tissue is irreversible. Treatment focuses on slowing disease progression and improving quality of life.

General Measures

Smoking cessation: The single most important step to slow disease progression.
Pulmonary rehabilitation: Breathing exercises, endurance training, and patient education to improve exercise capacity.
Vaccinations: Against influenza and pneumococcal disease to prevent respiratory infections.

Pharmacological Therapy

Bronchodilators: Short- and long-acting beta-agonists and anticholinergics to open the airways (e.g., salbutamol, tiotropium).
Inhaled corticosteroids: Used in patients with frequent exacerbations to reduce airway inflammation.
Alpha-1 antitrypsin replacement therapy: A specific treatment option for patients with confirmed deficiency.

Interventional and Surgical Options

Bronchoscopic lung volume reduction: Placement of endobronchial valves or coils to reduce hyperinflated lung areas.
Surgical lung volume reduction (LVRS): Surgical removal of severely damaged lung tissue.
Lung transplantation: Considered in end-stage disease when all other options have been exhausted.

Long-Term Oxygen Therapy

In patients with chronic hypoxemia (low blood oxygen levels), long-term oxygen therapy (at least 16 hours per day) has been shown to significantly improve survival and quality of life.

References

Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2024. Available at: https://goldcopd.org
Vogelmeier CF et al. - Diagnosis and Treatment of COPD Patients: Guidelines of the German Respiratory Society. Pneumologie. 2018;72(4):253-308.
Kasper DL et al. - Harrison's Principles of Internal Medicine, 21st edition. McGraw-Hill Education, 2022.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.